Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127048) titled 'Construction and Effect Evaluation of an Integrated Pathway for Early Diagnosis and Rapid Treatment of Lung Cancer Based on a Multidisciplinary Team' on June 23.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tianjin Beichen Hospital
Condition:
Lung cancer
Intervention:
Intervention group:MDT-Based Rapid Diagnosis and Treatment Integrated Pathway
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2026-07-01
Target Sample Size: Intervention group:80;Control group:80;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/...